Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. PRE 14A Proxy Proxy Statement (Preliminary)
  14. DEF 14A Proxy Proxy Statement
  15. DEF 14A Proxy Proxy Statement
  16. DEF 14A Proxy Proxy Statement
  17. PRE 14A Proxy Proxy Statement (Preliminary)
  18. DEF 14A Proxy Proxy Statement
  19. DEF 14A Proxy Proxy Statement
  20. DEF 14A Proxy Proxy Statement

Page 1 of 2 · 39 filings